These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 17259088)

  • 21. Probiotics in functional gastrointestinal disorders: what are the facts?
    Quigley EM
    Curr Opin Pharmacol; 2008 Dec; 8(6):704-8. PubMed ID: 18775516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials.
    Ford AC; Talley NJ; Quigley EM; Moayyedi P
    Dis Colon Rectum; 2009 Oct; 52(10):1805; author reply 1806. PubMed ID: 19966623
    [No Abstract]   [Full Text] [Related]  

  • 23. [Nutritional factors and nutritional therapy for irritable bowel syndrome--what is worthwhile?].
    Wächtershäuser A; Stein JM
    Z Gastroenterol; 2008 Mar; 46(3):279-91. PubMed ID: 18322884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probiotics and functional gastrointestinal disorders in children.
    Vandenplas Y; Benninga M
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S107-9. PubMed ID: 19300120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probiotics and the irritable bowel syndrome.
    Chassany O; Matuchansky C
    Aliment Pharmacol Ther; 2008 Apr; 27(7):616-7; author reply 617-8. PubMed ID: 18194493
    [No Abstract]   [Full Text] [Related]  

  • 26. New insights into Lactobacillus and functional intestinal disorders.
    Lombardo L
    Minerva Gastroenterol Dietol; 2008 Sep; 54(3):287-93. PubMed ID: 18614977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Irritable bowel syndrome: can nutrient manipulation help?
    Cabré E
    Curr Opin Clin Nutr Metab Care; 2010 Sep; 13(5):581-7. PubMed ID: 20531176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review article: probiotics for the treatment of irritable bowel syndrome--focus on lactic acid bacteria.
    Clarke G; Cryan JF; Dinan TG; Quigley EM
    Aliment Pharmacol Ther; 2012 Feb; 35(4):403-13. PubMed ID: 22225517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacterial overgrowth as a cause of irritable bowel syndrome.
    Riordan SM; Kim R
    Curr Opin Gastroenterol; 2006 Nov; 22(6):669-73. PubMed ID: 17053447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probiotics: their role in the treatment and prevention of disease.
    Doron S; Gorbach SL
    Expert Rev Anti Infect Ther; 2006 Apr; 4(2):261-75. PubMed ID: 16597207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probiotics and human health: a clinical perspective.
    Gill HS; Guarner F
    Postgrad Med J; 2004 Sep; 80(947):516-26. PubMed ID: 15356352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome.
    Zeng J; Li YQ; Zuo XL; Zhen YB; Yang J; Liu CH
    Aliment Pharmacol Ther; 2008 Oct; 28(8):994-1002. PubMed ID: 18671775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Irritable bowel syndrome: role of food in pathogenesis and management.
    Morcos A; Dinan T; Quigley EM
    J Dig Dis; 2009 Nov; 10(4):237-46. PubMed ID: 19906102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.
    Kajander K; Myllyluoma E; Rajilić-Stojanović M; Kyrönpalo S; Rasmussen M; Järvenpää S; Zoetendal EG; de Vos WM; Vapaatalo H; Korpela R
    Aliment Pharmacol Ther; 2008 Jan; 27(1):48-57. PubMed ID: 17919270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R; Nikfar S; Abdollahi M
    Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probiotics and diverticular disease.
    Sheth A; Floch M
    Nutr Clin Pract; 2009; 24(1):41-4. PubMed ID: 19244147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probiotics in functional intestinal disorders and IBS: proof of action and dissecting the multiple mechanisms.
    Marteau P
    Gut; 2010 Mar; 59(3):285-6. PubMed ID: 20207630
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatments targeting putative mechanisms in irritable bowel syndrome.
    Cremonini F; Talley NJ
    Nat Clin Pract Gastroenterol Hepatol; 2005 Feb; 2(2):82-8. PubMed ID: 16265125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microbial-gut interactions in health and disease. Irritable bowel syndrome.
    Verdu EF; Collins SM
    Best Pract Res Clin Gastroenterol; 2004 Apr; 18(2):315-21. PubMed ID: 15123072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical use of probiotics in the pediatric population.
    Wallace B
    Nutr Clin Pract; 2009; 24(1):50-9. PubMed ID: 19244149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.